19.61
price up icon4.20%   0.8093
 
loading
전일 마감가:
$18.80
열려 있는:
$18.95
하루 거래량:
170.83K
Relative Volume:
0.87
시가총액:
$350.30M
수익:
$116.88M
순이익/손실:
$-25.09M
주가수익비율:
-140.07
EPS:
-0.14
순현금흐름:
$-20.74M
1주 성능:
+1.24%
1개월 성능:
+3.49%
6개월 성능:
-10.18%
1년 성능:
+102.80%
1일 변동 폭
Value
$18.80
$19.85
1주일 범위
Value
$18.65
$19.85
52주 변동 폭
Value
$8.61
$29.82

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name
명칭
Rigel Pharmaceuticals
Name
전화
650-624-1100
Name
주소
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
Name
직원
164
Name
트위터
@rigelpharma
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
RIGL's Discussions on Twitter

RIGL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RIGL
Rigel Pharmaceuticals
19.60 345.83M 116.88M -25.09M -20.74M -0.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.63 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.71 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.92 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
565.44 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.14 27.29B 3.81B -644.79M -669.77M -6.24

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-04-03 재개 Piper Sandler Neutral
2022-06-09 다운그레이드 Citigroup Buy → Neutral
2022-06-08 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2022-06-08 다운그레이드 Piper Sandler Overweight → Neutral
2022-03-23 개시 B. Riley Securities Neutral
2020-11-09 다운그레이드 JP Morgan Overweight → Neutral
2019-11-15 재개 Cantor Fitzgerald Overweight
2019-09-26 재개 JP Morgan Overweight
2019-03-01 재확인 Cantor Fitzgerald Overweight
2018-08-27 개시 Citigroup Buy
2018-05-02 재확인 Cantor Fitzgerald Overweight
2017-12-21 재개 Piper Jaffray Overweight
2017-12-15 개시 Cantor Fitzgerald Overweight
2017-11-06 재개 H.C. Wainwright Buy
2017-03-09 재확인 H.C. Wainwright Buy
2016-08-31 재확인 H.C. Wainwright Buy
2016-08-30 재확인 Piper Jaffray Overweight
2016-07-13 개시 H.C. Wainwright Buy
2016-06-13 개시 Piper Jaffray Overweight
2016-04-22 업그레이드 JP Morgan Neutral → Overweight
2013-04-08 재확인 Stifel Buy
2012-11-29 개시 UBS Neutral
2012-11-06 재확인 Oppenheimer Outperform
2012-03-26 개시 Canaccord Genuity Hold
2010-12-10 다운그레이드 MP Advisors Outperform → Market Perform
모두보기

Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스

pulisher
Jul 20, 2025

What analysts say about Rigel Pharmaceuticals Inc. stockAccelerated investment success - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

(RIGL) Proactive Strategies - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 20, 2025

Is Rigel Pharmaceuticals Inc. a good long term investmentUnstoppable profit momentum - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

Rigel Pharmaceuticals Inc. Stock Analysis and ForecastTriple-digit returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Rigel Pharmaceuticals Inc. stock priceTriple-digit returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 15, 2025

What makes Rigel Pharmaceuticals Inc. stock price move sharplyHigh Potential Stock Ideas - newser.com

Jul 15, 2025
pulisher
Jul 15, 2025

Why Rigel Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL) - Insider Monkey

Jul 10, 2025
pulisher
Jul 10, 2025

(RIGL) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 10, 2025
pulisher
Jul 07, 2025

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | RIGL Stock News - GuruFocus

Jul 07, 2025
pulisher
Jul 07, 2025

Rigel Pharmaceuticals, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - 富途牛牛

Jul 07, 2025
pulisher
Jun 18, 2025

Recent 11% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 112% over 1 year - simplywall.st

Jun 18, 2025
pulisher
Jun 14, 2025

Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential By Investing.com - Investing.com Canada

Jun 14, 2025
pulisher
Jun 14, 2025

Rigel Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential - Investing.com

Jun 14, 2025
pulisher
Jun 11, 2025

High-grade Glioma Market Expected to Experience Major Growth by 2034, According to DelveInsight | Rigel Pharma, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharma - Barchart.com

Jun 11, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Nuveen Asset Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Makes New $1.03 Million Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation By Investing.com - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Takes $1.19 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Rigel Pharmaceuticals at Jefferies Conference: Strategic Growth and Innovation - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Rigel Pharma To Present At Jefferies Global Healthcare Conference; Webcast At 12:50 PM ET - Nasdaq

Jun 04, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Increases Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of “Hold” from Brokerages - Defense World

Jun 02, 2025
pulisher
May 29, 2025

Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Rigel to Present at the Jefferies Global Healthcare Conference - StreetInsider

May 29, 2025
pulisher
May 28, 2025

Director Lapointe Anthony Gregg was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4) - Quantisnow

May 28, 2025
pulisher
May 28, 2025

Director Hannah Alison L. was granted 2,500 shares, increasing direct ownership by 31% to 10,625 units (SEC Form 4) - Quantisnow

May 28, 2025
pulisher
May 28, 2025

Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? - sharewise

May 28, 2025
pulisher
May 28, 2025

Rigel to Present at the Jefferies Global Healthcare Conference | RIGL Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Rigel to Present at the Jefferies Global Healthcare Conference – Company Announcement - Financial Times

May 28, 2025
pulisher
May 26, 2025

Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential By Investing.com - Investing.com India

May 26, 2025
pulisher
May 26, 2025

Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential - Investing.com

May 26, 2025
pulisher
May 25, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Acquired by Northern Trust Corp - Defense World

May 25, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Grows Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 25, 2025
pulisher
May 23, 2025

Rigel Pharmaceuticals Approves Equity Plan Amendment - TipRanks

May 23, 2025
pulisher
May 22, 2025

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress | RIGL Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire

May 22, 2025
pulisher
May 22, 2025

Jane Street Group LLC Has $1.05 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 22, 2025
pulisher
May 18, 2025

17,123 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Acquired by Dimensional Fund Advisors LP - Defense World

May 18, 2025
pulisher
May 16, 2025

(RIGL) Investment Analysis - news.stocktradersdaily.com

May 16, 2025
pulisher
May 15, 2025

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st

May 15, 2025

Rigel Pharmaceuticals (RIGL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.67
price down icon 1.03%
$35.60
price up icon 0.17%
$102.58
price down icon 0.03%
$26.88
price up icon 1.05%
$110.44
price down icon 0.20%
biotechnology ONC
$290.46
price down icon 1.81%
자본화:     |  볼륨(24시간):